Inflammatory bowel disease
Gene: SLC9A3
Described as a monogenic cause of VEOIBD. 2 patients from unrelated families in a series of 9 cases with SLC9A3-related congenital sodium diarrhoea developed intestinal inflammation/IBD (PMID: 26358773). GWAS have indicated a strong association between SLC9A3 and IBD, and there are supportive mouse models (reviewed in PMID: 26358773).Included on a monogenic IBD gene panel proposed by The Paediatric IBD Porto Group of ESPGHAN (PMID: 33346580).
Sources: Expert ReviewCreated: 31 Jan 2021, 10:13 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Diarrhoea 8, secretory sodium, congenital 616868; Very Early Onset Inflammatory Bowel Disease
Publications
Gene: slc9a3 has been classified as Amber List (Moderate Evidence).
Gene: slc9a3 has been classified as Amber List (Moderate Evidence).
gene: SLC9A3 was added gene: SLC9A3 was added to Inflammatory bowel disease. Sources: Expert Review Mode of inheritance for gene: SLC9A3 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: SLC9A3 were set to 26358773; 33346580 Phenotypes for gene: SLC9A3 were set to Diarrhoea 8, secretory sodium, congenital 616868; Very Early Onset Inflammatory Bowel Disease Review for gene: SLC9A3 was set to AMBER